Altamira Therapeutics Quote - CYTO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.30

Bid

0.2921

Offer

0.2922

Volume

0.00 Day's Range 0.00

0.30 52 Week Range 3.49

Market Cap

969k

Previous Close

0.30

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

87,173

Shares Outstanding

3,230,000

Dividend Yield

PE Ratio

-2.54

Earnings Per Share (EPS)

-1.2

Revenue

158k

Net Profit

-3.87M

Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-4... Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. In addition, Altamira holds a 49% stake (with additional economic rights) in Altamira Medica AG, its commercial-stage legacy asset BentrioÂ®, an OTC nasal spray for allergic rhinitis. Further, the Company is in the process of partnering / divesting its inner ear legacy assets. Show more

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

altamiratherapeutics.com

Headquarters

Basel, Che

Founded

Altamira Therapeutics Ltd is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker CYTO. The last closing price for Altamira Therapeutics was US$0.30. Over the last year, Altamira Therapeutics shares have traded in a share price range of US$ 0.30 to US$ 3.49.

Altamira Therapeutics currently has 3,230,000 shares in issue. The market capitalisation of Altamira Therapeutics is US$969,000 . Altamira Therapeutics has a price to earnings ratio (PE ratio) of -2.54.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.3	0.3	0.3	0	0	CS
4	0	0	0.3	0.3	0.3	0	0	CS
12	-0.1599	-34.7684279191	0.4599	0.575	0.3	87173	0.43805541	CS
26	-0.61	-67.032967033	0.91	1.3344	0.3	237111	0.8583547	CS
52	-1.59	-84.126984127	1.89	3.49	0.3	594483	1.79860406	CS
156	-483.7	-99.9380165289	484	860	0.3	2198075	57.15000479	CS
260	-239.7	-99.875	240	1548	0.3	1777255	183.46352744	CS

CYTO - Frequently Asked Questions (FAQ)

What is the current Altamira Therapeutics share price?

The current share price of Altamira Therapeutics is US$ 0.30

How many Altamira Therapeutics shares are in issue?

Altamira Therapeutics has 3,230,000 shares in issue

What is the market cap of Altamira Therapeutics?

The market capitalisation of Altamira Therapeutics is USD 969k

What is the 1 year trading range for Altamira Therapeutics share price?

Altamira Therapeutics has traded in the range of US$ 0.30 to US$ 3.49 during the past year

What is the PE ratio of Altamira Therapeutics?

The price to earnings ratio of Altamira Therapeutics is -2.54

What is the cash to sales ratio of Altamira Therapeutics?

The cash to sales ratio of Altamira Therapeutics is 62.17

What is the reporting currency for Altamira Therapeutics?

Altamira Therapeutics reports financial results in CHF

What is the latest annual turnover for Altamira Therapeutics?

The latest annual turnover of Altamira Therapeutics is CHF 158k

What is the latest annual profit for Altamira Therapeutics?

The latest annual profit of Altamira Therapeutics is CHF -3.87M

What is the registered address of Altamira Therapeutics?

The registered address for Altamira Therapeutics is DORNACHERSTRASSE 210, BASEL, 4053

What is the Altamira Therapeutics website address?

The website address for Altamira Therapeutics is altamiratherapeutics.com

Which industry sector does Altamira Therapeutics operate in?

Altamira Therapeutics operates in the MED, DENTAL, HOSP EQ-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGOLMGO Global Inc	US$ 0.3779 (104.27%)	172.51M
CDTConduit Pharmaceuticals Inc	US$ 2.57 (65.81%)	9.07M
UPCUniverse Pharmaceuticals Inc	US$ 0.2598 (61.37%)	86.27M
RANDRand Capital Corporation	US$ 36.74 (59.67%)	20
ZOOZZOOZ Power Ltd	US$ 3.22 (56.31%)	46
BTMDBiote Corporation	US$ 2.07 (-56.96%)	43
ANIKAnika Therapeutics Inc	US$ 8.00 (-55.03%)	20
EDRYEuroDry Ltd	US$ 6.01 (-45.01%)	4
NKLANikola Corporation	US$ 0.4398 (-41.55%)	4.32M
PFCPremier Financial Corporation	US$ 17.01 (-39.89%)	5
MGOLMGO Global Inc	US$ 0.3779 (104.27%)	172.51M
UPCUniverse Pharmaceuticals Inc	US$ 0.2598 (61.37%)	86.27M
NIVFNewGenIvf Group Ltd	US$ 0.1922 (23.92%)	36.36M
LTRYLottery com Inc	US$ 1.68 (19.15%)	29.51M
RIMEAlgorhythm Holdings Inc	US$ 0.0205 (-3.76%)	24.39M